The DOI matches its Crossref record; 239 of the 239 references it cites were found in a registry or an index.
Virulence factors of medically important fungi
Open accessAbstract
Human fungal pathogens have become an increasingly important medical problem with the explosion in the number of immunocompromised patients as a result of cancer, steroid therapy, chemotherapy, and AIDS. Additionally, the globalization of travel and expansion of humankind into previously undisturbed habitats have led to the reemergence of old fungi and new exposure to previously undescribed fungi. Until recently, relatively little was known about virulence factors for the medically important fungi. With the advent of molecular genetics, rapid progress has now been made in understanding the basis of pathogenicity for organisms such as Aspergillus species and Cryptococcus neoformans. The twin technologies of genetic transformation and "knockout" deletion construction allowed for genetic tests of virulence factors in these organisms. Such knowledge will prove invaluable for the rational design of antifungal therapies. Putative virulence factors and attributes are reviewed for Aspergillus species, C. neoformans, the dimorphic fungal pathogens, and others, with a focus upon a molecular genetic approach. Candida species are excluded from coverage, having been the subject of numerous recent reviews. This growing body of knowledge about fungal pathogens and their virulence factors will significantly aid efforts to treat the serious diseases they cause.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–239 of 239
A transformant of Aspergillus fumigatus deficient in the antigenic cytotoxin ASPFI
Paris, S., Monod, M., Diaquin, M., Lamy, B., Arruda, L. K., Punt, P. J., & Latgé, J. P. (1993) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1993.tb06357.x · Cited by 44
Eissenberg, L. G., West, J. L., Woods, J. P., & Goldman, W. E. (1991) · Infection and Immunity · doi:10.1128/iai.59.5.1639-1646.1991 · Cited by 43
Washburn, R. G., Bryant-Varela, B. J., Julian, N. C., & Bennett, J. E. (1991) · Molecular Immunology · doi:10.1016/0161-5890(91)90160-l · Cited by 41
Levitz, S. M. (1989) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30243-9 · Cited by 40
Self-citationCameron, M. L., Granger, D. L., Matthews, T. J., & Weinberg, J. B. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.1.60 · Cited by 39
Perfect, J. R. (1989) · PubMed · Cited by 39
Enzymatic degradation of the walls of spherules ofCoccidioides immitis
Hector, R. F., & Pappagianis, D. (1982) · Experimental Mycology · doi:10.1016/0147-5975(82)90088-3 · Cited by 37
Morphological transition in the human fungal pathogen Histoplasma capulatum
Maresca, B., Carratù, L., & Kobayashi, G. S. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90596-7 · Cited by 37
Conditional virulence of a p-aminobenzoic acid-requiring mutant of Aspergillus fumigatus
Sandhu, D. K., Sandhu, R., Khan, Z., & Damodaran, V. N. (1976) · Infection and Immunity · doi:10.1128/iai.13.2.527-532.1976 · Cited by 36
Blackstock, R., McCormack, J. M., & Hall, N. K. (1987) · Infection and Immunity · doi:10.1128/iai.55.1.233-239.1987 · Cited by 35
Maresca, B., & Kobayashi, G. S. (1993) · PubMed · Cited by 35
An immunoreactive, water-soluble conidial wall fraction of Coccidioides immitis
Cole, G. T., Kirkland, T. N., & Sun, S. H. (1987) · Infection and Immunity · doi:10.1128/iai.55.3.657-667.1987 · Cited by 34
Inhibition of Different Phases of Coccidioides immitis by Human Neutrophils or Hydrogen Peroxide
Galgiani, J. N. (1986) · The Journal of Infectious Diseases · doi:10.1093/infdis/153.2.217 · Cited by 33
Utilization of indole compounds by Cryptococcus neoformans to produce a melanin-like pigment
Kwon-Chung, K. J., Tom, W., & Costa, J. L. (1983) · Journal of Clinical Microbiology · doi:10.1128/jcm.18.6.1419-1421.1983 · Cited by 32
Genetic study of oxygen resistance and melanization in Cryptococcus neoformans
Emery, H. S., Shelburne, C. P., Bowman, J. P., Fallon, P. G., Schulz, C. A., & Jacobson, E. S. (1994) · Infection and Immunity · doi:10.1128/iai.62.12.5694-5697.1994 · Cited by 31
Cerebral mucormycosis in diabetic mice after intrasinus challenge
Waldorf, A. R., & Diamond, R. D. (1984) · Infection and Immunity · doi:10.1128/iai.44.1.194-195.1984 · Cited by 31
Effect of Hypertonic Solutes Upon the Polysaccharide Capsule in Cryptococcus neoformans
Jacobson, E. S., Tingler, M. J., & Quynn, P. L. (1989) · Mycoses · doi:10.1111/j.1439-0507.1989.tb02163.x · Cited by 31
Hogan, L. H., & Klein, B. S. (1997) · Gene · doi:10.1016/s0378-1119(96)00713-5 · Cited by 31
Self-citationIn vitrosusceptibility ofCryptococcus neoformansto steroids
Mohr, J. A., Long, H., McKown, B. A., & MUCHMORE, H. G. (1972) · Medical Mycology · doi:10.1080/00362177285190331 · Cited by 30
Characterization of a Phenol Oxidase from Cryptococcus neoformans var. neoformans
Ikeda, R., Shinoda, T., Morita, T., & Jacobson, E. S. (1993) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1993.tb01702.x · Cited by 29
Coccidioides immitis fractions which are antigenic for immune T lymphocytes
Kirkland, T. N., Zhu, S. W., Kruse, D., Hsu, L. L., Seshan, K. R., & Cole, G. T. (1991) · Infection and Immunity · doi:10.1128/iai.59.11.3952-3961.1991 · Cited by 29
In vivo complement activation and binding of C3 to encapsulated Cryptococcus neoformans
Truelsen, K., Young, T., & Kozel, T. R. (1992) · Infection and Immunity · doi:10.1128/iai.60.9.3937-3939.1992 · Cited by 28
Sundstrom, J. B., & Cherniak, R. (1993) · Infection and Immunity · doi:10.1128/iai.61.4.1340-1345.1993 · Cited by 27
Regulation of mannitol biosynthesis and degradation by Cryptococcus neoformans
Niehaus, W. G., & Flynn, T. J. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.3.651-655.1994 · Cited by 25
Cole, G. T., Zhu, S. W., Hsu, L. L., Kruse, D., Seshan, K. R., & Wang, F. (1992) · Infection and Immunity · doi:10.1128/iai.60.2.416-427.1992 · Cited by 24
Frosco, M., Chase, T., & Macmillan, J. D. (1994) · Mycopathologia · doi:10.1007/bf01371095 · Cited by 24
Heterogeneity of phenol oxidases in Cryptococcus neoformans
Ikeda, R., & Jacobson, E. S. (1992) · Infection and Immunity · doi:10.1128/iai.60.9.3552-3555.1992 · Cited by 24
Harrison, T. S., Kornfeld, H., & Levitz, S. M. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/172.3.665 · Cited by 24
Self-citationPolacheck, I. (1991) · Zentralblatt für Bakteriologie · doi:10.1016/s0934-8840(11)80225-2 · Cited by 23
Hiruma, M., & Kagawa, S. (1986) · Mycopathologia · doi:10.1007/bf00437167 · Cited by 23
Powell, B. L., & Drutz, D. J. (1984) · Infection and Immunity · doi:10.1128/iai.45.3.784-786.1984 · Cited by 22
Iron assimilation inCryptococcus neoformans
Jacobson, E. S., & Vartivarian, S. E. (1992) · Medical Mycology · doi:10.1080/02681219280000601 · Cited by 22
MUCORMYCOSIS IN DIABETIC KETOACIDOSIS: Role of Unbound Iron Binding Capacity of Transferrin
Abe, F., Shibuya, H., Tateyama, M., Ommura, Y., Azumi, N., & Kazuyuki, K. (1986) · Acta Pathologica Japonica · doi:10.1111/j.1440-1827.1986.tb02822.x · Cited by 21
Iron acquisition byCryptococcus neoformans
Vartivarian, S. E., Cowart, R. E., Anaissie, E. J., Tashiro, T., & Sprigg, H. A. (1995) · Medical Mycology · doi:10.1080/02681219580000331 · Cited by 19
Pulmonary Infections and Immunity
(1994) · Infectious agents and pathogenesis · doi:10.1007/978-1-4899-1063-9 · Cited by 18
Richardson, M. D., White, L. J., McKay, I. C., & Shankland, G. S. (1993) · Medical Mycology · doi:10.1080/02681219380000241 · Cited by 8
Levitz, S. M., Tabuni, A., Wagner, R., Kornfeld, H., & Smail, E. H. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/166.4.866 · Cited by 6
Self-citationMolecular approaches to identify novel targets for future development of antifungal agents
Maresca, B., Bennett, J. E., Fonzi, W. A., Hitchcock, C. A., Lodge, J. K., & Williamson, P. R. (1994) · Medical Mycology · doi:10.1080/02681219480000911 · Cited by 5
Chaudhary, B., & Singh, B. (1983) · Mycoses · doi:10.1111/j.1439-0507.1983.tb03233.x · Cited by 4
Cited by
Aspergillus fumigatus and Aspergillosis
Latgé, J.-P. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.2.310 · Cited by 2,307
Romani, L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2939 · Cited by 1,793
Romani, L. (2004) · Nature Reviews Immunology · doi:10.1038/nri1255 · Cited by 758
Sporothrix schenckii and Sporotrichosis
Barros, M. B. D. L., de Almeida Paes, R., & Schubach, A. O. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00007-11 · Cited by 711
Current Knowledge of Trichosporon spp. and Trichosporonosis
Colombo, A. L., Padovan, A. C. B., & Chaves, G. M. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00003-11 · Cited by 545
Metadata
- Authors
- Hogan, L. H., Klein, B. S., & Levitz, S. M.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 1996-10
- Volume
- 9
- Issue
- 4
- Pages
- 469-488
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2126154103
- Cited by
- 271
- References
- 239
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.